Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gerken

Showing results (241-250 of 307) with videos related to

Pageof 31
Sort By:
International Journal of Medical Microbiology : IJMM|September 20, 2015
Performance characteristics of the VERSANT hepatitis C virus RNA 1.0 (kPCR) assayNico Grüner, S Viazov, K Korn, et al.
Hepatology (Baltimore, Md.)|August 1, 1997
A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxisU Naumann, U Protzer-Knolle, T Berg, et al.
Frontiers in Plant Science|November 22, 2018
Down-Selection and Outdoor Evaluation of Novel, Halotolerant Algal Strains for Winter CultivationLukas R Dahlin, Stefanie Van Wychen, Henri G Gerken, et al.
Journal of Clinical Microbiology|June 2, 2000
Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determinationG Gerken, T Rothaar, M G Rumi, et al.
Liver|December 30, 1998
Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis BH F Löhr, S Krug, W Herr, et al.
Clinical and Experimental Immunology|July 1, 1996
Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infectionW O Böcher, S Herzog-Hauff, W Herr, et al.
European Journal of Medical Research|April 20, 2004
Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differencesTill Neumann, T Woiwod, A Neumann, et al.
The Clinical Investigator|December 1, 1994
Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infectionT Wölfel, P Schirmacher, J Schlaak, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2009
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipientsS Beckebaum, C Klein, J Varghese, et al.
Journal of Hepatology|June 1, 1996
Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitisF Gohlke, A W Lohse, H P Dienes, et al.
Pageof 31

Showing results (241-250 of 307) with videos related to

Sort By:
Pageof 31
International Journal of Medical Microbiology : IJMM|September 20, 2015
Performance characteristics of the VERSANT hepatitis C virus RNA 1.0 (kPCR) assayNico Grüner, S Viazov, K Korn, et al.
Hepatology (Baltimore, Md.)|August 1, 1997
A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxisU Naumann, U Protzer-Knolle, T Berg, et al.
Frontiers in Plant Science|November 22, 2018
Down-Selection and Outdoor Evaluation of Novel, Halotolerant Algal Strains for Winter CultivationLukas R Dahlin, Stefanie Van Wychen, Henri G Gerken, et al.
Journal of Clinical Microbiology|June 2, 2000
Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determinationG Gerken, T Rothaar, M G Rumi, et al.
Liver|December 30, 1998
Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis BH F Löhr, S Krug, W Herr, et al.
Clinical and Experimental Immunology|July 1, 1996
Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infectionW O Böcher, S Herzog-Hauff, W Herr, et al.
European Journal of Medical Research|April 20, 2004
Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differencesTill Neumann, T Woiwod, A Neumann, et al.
The Clinical Investigator|December 1, 1994
Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infectionT Wölfel, P Schirmacher, J Schlaak, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2009
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipientsS Beckebaum, C Klein, J Varghese, et al.
Journal of Hepatology|June 1, 1996
Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitisF Gohlke, A W Lohse, H P Dienes, et al.
Pageof 31